Budget Amount *help |
¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000)
Fiscal Year 2014: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2013: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2012: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Outline of Final Research Achievements |
Using a human hematopoietic stem cell-transplanted humanized mouse model, we found a series of HIV-1 infection mechanisms. Vpu contributes to efficient spread of HIV-1 in vivo. Vpu concomitantly downregulates tetherin and CD4 from the surface of infected cells. Vpr induces depletion of CCR5+ FOXP3+ CD4+ regulatory T cells (Treg) for enhancing viremia of CCR5-tropic HIV-1. APOBEC3F and APOBEC3G fundamentally work as restriction factors against HIV-1 in vivo, but at the same time, that APOBEC3F are capable of promoting viral diversification and evolution in vivo.
|